World Journal of Oncology

recept

resep masakan indonesia
resep masakan indonesia
delicious recipe

Frequency: Bimonthly
Journal Access: Open Access

ISSN-print: 1920-4531

ISSN-online: 1920-454X
Journal scope: World Journal of Oncology is an open access, peer-reviewed, international journal, publishes original contributions describing basic research and clinical investigation of cancer, on the cellular, molecular, prevention, diagnosis, therapy and prognosis aspects. The submissions can be basic research or clinical investigation oriented.
Indexed and covered: Chemical Abstracts (CA); Directory of Open Access Journals (DOAJ); JournalTOCs; Google Scholar; PubMed and PubMed Central: selected citations; Elsevier EMBASE; EBSCO; Worldcat.

Journal archiving and digital preservation: Portico




Highlights

 

 

Featured

 

Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients
Mammalian cells contain three functional RAS proto-oncogenes, known as H-RAS, K-RAS, and N-RAS, which encode small GTP-binding proteins in terms of p21rass. RAS genes have been elucidated as major participants in the development and progression of cancer. A single nucleotide polymorphism (SNP) at H-RAS cDNA position 81 T→C (rs12628) has been found to be associated with the risk of many human cancers like gastrointestinal, oral, colon, bladder and thyroid carcinomas. Read the Full Text

Liver Metastases in Prostate Carcinoma Represent a Relatively Aggressive Subtype Refractory to Hormonal Therapy and Short-Duration Response to Docetaxel Monotherapy
We report a single institution’s experience from a small series of patients suggesting that liver metastasis in metastatic castration-refractory prostate cancer (mCRPC) represents a relatively aggressive subtype that is refractory to hormonal manipulation treatment, including luteinizing hormone-releasing hormone agonist (LA) and abiraterone (Ab) therapy, although docetaxel is briefly effective. Full Text




Image of the Issue

The Risk of Misdiagnosing the Primary Site Responsible for Bone Metastases in Patients With Chronic Lymphocytic Leukemia and a Second Primary Carcinoma
Chronic lymphocytic leukemia (CLL) is a common malignancy which may coexist with other primary cancers. CLL is rarely the cause of solitary bone lesions; such lesions in the context of CLL are believed to result from either Richter’s transformation or metastasis from another primary malignancy. Renal cell carcinoma (RCC), on the other hand, is a malignancy which frequently metastasizes to bone and may cause an osteolytic solitary bone lesion. Full Text

Current Issue

Past Issues


Vol. 6, No. 2, Apr 2015

Table of Contents

Original Article

Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients Abstract HTML PDF
Rashid Mir, Imtiyaz Ah, Jamsheed Javid, Mariyam Zuberi, Sameer Guru, Masroor Mirza, Shazia Farooq, Prasant Yadav, Prakash C. Ray, Naresh Gupta, Alpana Saxena 321-328
doi: http://dx.doi.org/10.14740/wjon912e

Case Report

Active Monitoring of a Humeral Osteoblastoma in a 52-Year-Old Male: A Case Report Abstract HTML PDF
Juliette Bouchet, Donia Lassoued, Nathalie Boussier, Jordan Birebent, Stephane Oustric, Marie-Eve Rouge-Bugat 329-331
doi: http://dx.doi.org/10.14740/wjon871w
The Risk of Misdiagnosing the Primary Site Responsible for Bone Metastases in Patients With Chronic Lymphocytic Leukemia and a Second Primary Carcinoma Abstract HTML PDF
Georges Hatoum, Cyrus Meshkin, Sufana Alkhunaizi, Richard Levene, Julie Formoso-Onofrio 332-334
doi: http://dx.doi.org/10.14740/wjon873e
Langerhan Cell Histiocytosis: A Rare Disorder With a Rare Presentation Abstract HTML PDF
Divya Byragani, Krishna Baradhi, Igor Schendrick, Supriya Koya 335-337
doi: http://dx.doi.org/10.14740/wjon880w
Primary Hepatic Non-Hodgkin’s Lymphoma: An Enigma Beyond the Liver, a Case Report Abstract HTML PDF
Shalini Thapar Laroia, Archana Rastogi, Dipanjan Panda, Shiv Kumar Sarin 338-344
doi: http://dx.doi.org/10.14740/wjon900w
Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa Abstract HTML PDF
Dinesh Giri, Renuka Ramakrishnan, James Hayden, Lynda Brook, Urmi Das, M. Zulf Mughal, Peter Selby, Poonam Dharmaraj, Senthil Senniappan 345-348
doi: http://dx.doi.org/10.14740/wjon907w
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

World Journal of Oncology, bimonthly, ISSN 1920-4531 (print), 1920-454X (online), published by Elmer Press Inc.     
The content of this site is intended for health care professionals.
This is an open-access journal, published articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.

website: www.wjon.org   editorial contact: editor@wjon.org
Address: 9160 Boul Leduc, Bureau 410, Brossard, Quebec, J4Y 0E3, Canada

© Elmer Press Inc. All Rights Reserved.